Table 1 Characterization of the mode of programmed endothelial cell death.
From: Research advances on the role of programmed endothelial cell death in sepsis
PCD | Main processes and pathways | Cell membrane and nucleus changes | Inflammation | Reference | |
|---|---|---|---|---|---|
Apoptosis | Regulatory receptor | Exogenous: death-receptor ligand (Fas-associated death structural domain)/dependent receptor ligand | Nucleus: chromatin condensed and broken, nucleus consolidated, autophagosomes formed; Cytosol: cellular integrity, crumpling, cytoplasmic efflux, and vacuolization of the cytosol membrane. | LPS-IL-6, PD-L1-HIF-α, NLRX1-TNF-α; Promotes IκB degradation, NF-κB nuclear translocation, YAP phosphorylation, and activates apoptotic gene expression. | |
Endogenous: Cyc release from mitochondrial damage, oxidative stress, etc. | |||||
Effector genes and proteins | Common apoptosis-related genes: Bax, Bcl-2, Bcl-xL, p53, etc. | ||||
Executioner caspases: caspase-3/6/7 | |||||
Initiator Caspases: caspase-8/9/10 | |||||
Mitochondria-cleave: Cyt-c, SMAC, mtDNA, etc. | |||||
Main process | Apoptotic vesicle formation; Initiation of protein substrate hydrolysis; DNA and key regulatory protein fragmentation. | ||||
Effect | Altered vascular permeability; Inflammatory factor release; Impairment of organ function. | ||||
Necroptosis | Regulatory receptor | RIPK1/3 | Nucleus: chromatin breaks, DNA fragmentation Cell membrane: rupture of the cell membrane, discharge of cytoplasmic contents leading to inflammation and other reactions | Necrotic apoptosis occurs in response to TNF, Fas, or TRAIL, among others, and has a highly proinflammatory effect | |
Effector proteins | MIKL | ||||
Main process | RIPK1/3 activation, phosphorylation of MIKL, necrotic apoptotic cell membrane rupture, and content release | ||||
Effect | Altered vascular permeability; the Inflammatory and cytokine storms; Coagulation abnormalities; Organ function impairment | ||||
Pyroptosis | Regulatory receptor | Classical pyroptosis pathway: NLRP3 captures ASC cleavage of GSDMD-N; activation of caspase-1 by LPS-HMGB1, NLRP-1/3, NLRC4 | Nucleus: chromatin breaks, DNA fragmentation; Cell membrane: formation of membrane pores, swelling and rupture of the cell, discharge of cytoplasmic contents, triggering inflammatory reactions. | Pyroptosis is a natural immune response triggered by the activation of inflammatory vesicle assembly, which promotes the mature secretion of inflammatory factors such as IL-1β and exacerbates the local inflammatory response | |
Non-classical pyroptosis pathway: caspase-11 (murine origin), caspase-4/5 (human origin) | |||||
Effector proteins | Classical pathway: GSDMD-N integration to form membrane pores; casepase-1/3/9 | ||||
Non-classical pathway: caspse-11, caspase-4/5 (human source) | |||||
Main process | Inflammatory vesicle NLRP3-ASC-GSDMD-N assembly activation, membrane pore formation, proinflammatory cytokine maturation, and release | ||||
Effect | Altered vascular permeability. Inflammatory response; Cytokine storm; Coagulation abnormalities; Organ function impairment | ||||
Ferroptosis | Regulatory receptor | GPX4 over depletion, NCOA4 autophagy-dependent iron death | Nucleus: no change Cell membrane: ruptured Mitochondria: outer mitochondrial membrane ruptured and crumpled; mitochondria darkly colored | Activation of JAK-STAT, NF-ÎşB, inflammatory vesicles, cGAS-STING, and MAPK signaling pathways can lead to iron death | |
Effector genes and proteins | Ferritin degradation; TFRC/HSPβ1-TFR-1; Nfr2-ROS; NCOA4 activation of the ATG5-ATG7-NCOA4 autophagy pathway, culminating in ferric iron overload | ||||
Main process | Iron ion-dependent lipid peroxide accumulation, iron overload, and (GPX4) downregulation | ||||
Effect | Altered vascular permeability; Inflammatory response; Impairment of organ function | ||||
PANoptosis | Molecular mechanisms | PANoptotic vesicles are downstream molecular initiation switches. Currently, the more explicit PANoptotic upstream molecules include ZBP1, AIM2, RIPK1, etc. The known pathways are: S100a8/a9-Nrf1-PANoptosis; (CIRP)-ZBP1-PANoptosis; EIF2AK2-AIM2-PANoptosis, and the specific pathways need to be clarified. | - | NLRP12 drives inflammatory vesicle and PANoptosome activation through IRF1 and TLR2/4 in response to PAMP and TNF, causing cell death and promoting inflammation. | |